CASI Pharmaceuticals
CASI
#10160
Rank
NZ$34.18 M
Marketcap
NZ$1.66
Share price
-7.98%
Change (1 day)
-64.53%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.81. In 2024 the company made an earnings per share (EPS) of NZ-$4.45 a decrease over its 2023 EPS that were of NZ-$3.51.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.654.53%
2024NZ-$4.4526.73%
2023NZ-$3.51-32.89%
2022NZ-$5.2311.9%
2021NZ-$4.68-38.44%
2020NZ-$7.60-8.96%
2019NZ-$8.3450%
2018NZ-$5.5677.78%
2017NZ-$3.135.88%
2016NZ-$2.95-22.73%
2015NZ-$3.82-76.09%
2014NZ-$15.99318.18%
2013NZ-$3.82-71.79%
2012NZ-$13.5665.96%
2011NZ-$8.17-50%
2010NZ-$16.34-18.97%
2009NZ-$20.16-63.64%
2008NZ-$55.453.57%
2007NZ-$53.54-60.56%
2006NZ-$135.7597.22%
2005NZ-$68.83-2.7%
2004NZ-$70.74-45.59%
2003NZ-$130.02-61.8%
2002NZ-$340.34-25.52%
2001NZ-$456.97-21.38%
2000NZ-$581.2513.86%
1999NZ-$510.51149.53%
1998NZ-$204.5998.15%
1997NZ-$103.2510.2%
1996NZ-$93.69